Niroshan Nadarajah

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

The ASH HematOmics Program supports integrative analysis of genomic and clinical data in hematologic diseases.

The ASH HematOmics Program supports integrative analysis of genomic and clinical data in hematologic diseases.

Journal: Blood
Published: October 16, 2025

Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.

Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.

Journal: Blood cancer journal
Published: December 05, 2024

Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.

Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.

Journal: Leukemia
Published: February 21, 2024

Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP-ALL of all age classes.

Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP-ALL of all age classes.

Journal: HemaSphere
Published: December 01, 2023

Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase.

Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase.

Journal: Leukemia
Published: October 20, 2023

The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.

The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.

Journal: Blood advances
Published: August 07, 2023

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.

Journal: Blood
Published: May 17, 2023

Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS.

Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS.

Journal: Blood advances
Published: March 27, 2023

Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke.

Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke.

Journal: Stroke
Published: February 15, 2023

Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?

Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?

Journal: Leukemia
Published: December 02, 2022

Molecular landscape of immune pressure and escape in aplastic anemia.

Molecular landscape of immune pressure and escape in aplastic anemia.

Journal: Leukemia
Published: July 09, 2022

Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation.

Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation.

Journal: Molecular biology reports
Published: July 06, 2022
Showing 1-12 of 51

Last Updated: 09/26/2026